Clinical Trial Update: PTH Comparison in Post Menopausal Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing parathyroid hormone therapy in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Post-Menopausal | Phase 3 | Status: COMPLETED